AU6539199A - Process and intermediates for preparing 5-lipoxygenase inhibitors - Google Patents
Process and intermediates for preparing 5-lipoxygenase inhibitors Download PDFInfo
- Publication number
- AU6539199A AU6539199A AU65391/99A AU6539199A AU6539199A AU 6539199 A AU6539199 A AU 6539199A AU 65391/99 A AU65391/99 A AU 65391/99A AU 6539199 A AU6539199 A AU 6539199A AU 6539199 A AU6539199 A AU 6539199A
- Authority
- AU
- Australia
- Prior art keywords
- compound
- formula
- process according
- alkyl
- och
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11322198P | 1998-12-22 | 1998-12-22 | |
| US60113221 | 1998-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6539199A true AU6539199A (en) | 2000-06-29 |
Family
ID=22348241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU65391/99A Abandoned AU6539199A (en) | 1998-12-22 | 1999-12-21 | Process and intermediates for preparing 5-lipoxygenase inhibitors |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6194585B1 (2) |
| EP (1) | EP1029865B1 (2) |
| JP (2) | JP3468729B2 (2) |
| KR (1) | KR100362789B1 (2) |
| CN (1) | CN1258675A (2) |
| AR (1) | AR019497A3 (2) |
| AT (1) | ATE265460T1 (2) |
| AU (1) | AU6539199A (2) |
| BR (1) | BR9905918A (2) |
| CA (1) | CA2289422A1 (2) |
| CZ (1) | CZ453699A3 (2) |
| DE (1) | DE69916778D1 (2) |
| HU (1) | HUP9904282A3 (2) |
| ID (1) | ID24014A (2) |
| IL (1) | IL132897A0 (2) |
| IN (1) | IN187165B (2) |
| PL (1) | PL337397A1 (2) |
| RU (1) | RU2181722C2 (2) |
| TR (1) | TR199903204A2 (2) |
| TW (1) | TW455586B (2) |
| YU (1) | YU59399A (2) |
| ZA (1) | ZA997113B (2) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4569187B2 (ja) * | 2004-06-17 | 2010-10-27 | 宇部興産株式会社 | ４−シアノテトラヒドロピランの製法 |
| EP1834953A1 (en) * | 2006-03-14 | 2007-09-19 | Ranbaxy Laboratories Limited | Tetrahydropyrane derivatives as 5-lipoxygenase inhibitors |
| BRPI0718672A2 (pt) * | 2006-11-27 | 2013-11-26 | Pfizer Prod Inc | Análogos de pirazol |
| NZ720946A (en) | 2009-04-29 | 2017-09-29 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| CN120943743A (zh) * | 2019-12-23 | 2025-11-14 | 思研（Sri）国际顾问与咨询公司 | 脂氧合酶抑制剂 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5374637A (en) * | 1989-03-22 | 1994-12-20 | Janssen Pharmaceutica N.V. | N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives |
| US5212198A (en) * | 1990-05-10 | 1993-05-18 | G. D. Searle & Co. | Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof |
| EP0462830B1 (en) * | 1990-06-21 | 1995-10-18 | Zeneca Limited | Cyclic ether derivatives |
| IE913866A1 (en) * | 1990-11-28 | 1992-06-03 | Ici Plc | Aryl derivatives |
| IE914005A1 (en) * | 1990-12-14 | 1992-06-17 | Zeneca Ltd | Novel intermediates |
| EP0505122A1 (en) * | 1991-03-21 | 1992-09-23 | Zeneca Limited | Alpha, alpha-dialkylbenzyl derivatives |
| EP0540165A1 (en) * | 1991-10-03 | 1993-05-05 | Zeneca Limited | Alkanoic acid derivatives |
| PL176522B1 (pl) * | 1993-06-14 | 1999-06-30 | Pfizer | Nowe pochodne imidazolu |
| US5883106A (en) * | 1994-10-18 | 1999-03-16 | Pfizer Inc. | 5-lipoxygenase inhibitors |
| SK281577B6 (sk) * | 1994-10-18 | 2001-05-10 | Pfizer Inc. | Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze |
-
1999
- 1999-08-24 US US09/387,707 patent/US6194585B1/en not_active Expired - Fee Related
- 1999-11-11 IL IL13289799A patent/IL132897A0/xx unknown
- 1999-11-12 DE DE69916778T patent/DE69916778D1/de not_active Expired - Lifetime
- 1999-11-12 EP EP99309046A patent/EP1029865B1/en not_active Expired - Lifetime
- 1999-11-12 AT AT99309046T patent/ATE265460T1/de not_active IP Right Cessation
- 1999-11-12 CA CA002289422A patent/CA2289422A1/en not_active Abandoned
- 1999-11-15 ZA ZA9907113A patent/ZA997113B/xx unknown
- 1999-11-16 JP JP32599999A patent/JP3468729B2/ja not_active Expired - Fee Related
- 1999-11-16 HU HU9904282A patent/HUP9904282A3/hu unknown
- 1999-11-16 RU RU99124413/04A patent/RU2181722C2/ru not_active IP Right Cessation
- 1999-11-17 TW TW088120072A patent/TW455586B/zh not_active IP Right Cessation
- 1999-11-17 YU YU59399A patent/YU59399A/sh unknown
- 1999-11-18 AR ARP990105879A patent/AR019497A3/es unknown
- 1999-11-18 IN IN814BO1999 patent/IN187165B/en unknown
- 1999-11-22 ID IDP991082D patent/ID24014A/id unknown
- 1999-12-14 CZ CZ19994536A patent/CZ453699A3/cs unknown
- 1999-12-21 KR KR1019990059661A patent/KR100362789B1/ko not_active Expired - Fee Related
- 1999-12-21 AU AU65391/99A patent/AU6539199A/en not_active Abandoned
- 1999-12-21 BR BR9905918-5A patent/BR9905918A/pt not_active IP Right Cessation
- 1999-12-21 CN CN99126450A patent/CN1258675A/zh active Pending
- 1999-12-22 TR TR1999/03204A patent/TR199903204A2/xx unknown
- 1999-12-22 PL PL99337397A patent/PL337397A1/xx not_active Application Discontinuation
-
2003
- 2003-05-13 JP JP2003134568A patent/JP2004002415A/ja not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TW455586B (en) | 2001-09-21 |
| TR199903204A2 (xx) | 2000-07-21 |
| ATE265460T1 (de) | 2004-05-15 |
| HUP9904282A3 (en) | 2001-04-28 |
| CZ453699A3 (cs) | 2000-07-12 |
| BR9905918A (pt) | 2000-09-26 |
| IN187165B (2) | 2002-02-23 |
| RU2181722C2 (ru) | 2002-04-27 |
| ZA997113B (en) | 2001-05-15 |
| KR100362789B1 (ko) | 2002-11-30 |
| AR019497A3 (es) | 2002-02-20 |
| EP1029865B1 (en) | 2004-04-28 |
| PL337397A1 (en) | 2000-07-03 |
| HUP9904282A2 (hu) | 2000-12-28 |
| EP1029865A2 (en) | 2000-08-23 |
| US6194585B1 (en) | 2001-02-27 |
| JP2000191654A (ja) | 2000-07-11 |
| YU59399A (sh) | 2002-11-15 |
| CA2289422A1 (en) | 2000-06-22 |
| IL132897A0 (en) | 2001-03-19 |
| HU9904282D0 (en) | 2000-01-28 |
| JP2004002415A (ja) | 2004-01-08 |
| ID24014A (id) | 2000-06-22 |
| EP1029865A3 (en) | 2000-11-08 |
| DE69916778D1 (de) | 2004-06-03 |
| KR20000052537A (ko) | 2000-08-25 |
| JP3468729B2 (ja) | 2003-11-17 |
| CN1258675A (zh) | 2000-07-05 |
| MX9912076A (2) | 2000-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0254322B1 (en) | Benzimidazole derivatives | |
| EP0672031B1 (en) | Catechol diethers as selective pde iv inhibitors | |
| RS59399B1 (sr) | Antitela protiv cd38 za lečenje multiplog mijeloma | |
| EP0138464A2 (en) | 2-Amino-5-hydroxy-4-methylpyrimidine derivatives | |
| IE46811B1 (en) | Aminoalkyl thiophene derivatives | |
| US4281127A (en) | Trans-3-(4-oxo-4H-quinazolin-3-yl)-2-propenoic acid derivatives | |
| KR20060133592A (ko) | 알킬피페라진- 및 알킬호모피페라진-카르복실레이트의유도체, 이의 제조 방법 및 ｆａａｈ 효소 억제제로서의용도 | |
| EP0705251A1 (en) | Imidazole derivatives as therapeutic agents | |
| HU208813B (en) | Process for producing substituted n-(quinolin-2-yl-methoxy)-benzylsulfonylureas and pharmaceutical compositions comprising such compounds | |
| US6194585B1 (en) | Process for preparing 5-lipoxygenase inhibitors | |
| IE894209L (en) | Benzene derivatives, their preparation and pharmaceutical¹compositions in which they are present | |
| US4946862A (en) | Thiophene derivative and process for preparing the same | |
| EP0029306B1 (en) | Aminoalkyl compounds, their production and pharmaceutical compositions containing them | |
| CA2007785C (en) | 1-[3-(2-hydroxy-3-alkylaminopropoxy)-2-thienyl] -3-phenyl-1-propanones and a process for the preparation thereof | |
| JPH10512578A (ja) | イミダゾール誘導体、その製造およびｓ−アデノシルメチオニンデカルボキシラーゼ（＝ｓａｍｄｃ）阻害剤としてのその使用 | |
| US4507296A (en) | Tetrazoles, pharmaceutical use and compositions | |
| CA1210392A (fr) | Procede pour la preparation d'amides n-substitues, et les amides ainsi obtenus | |
| US4518598A (en) | 1,2,4-Triazole-3-amines, their pharmaceutical compositions and method of use | |
| FI66872B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara tino(3,2-c)- och tieno(2,3-c)pyridinderivat | |
| MXPA99012076A (en) | Procedure and intermediate compounds for preparing 5-lipoxigen inhibitors | |
| CA1188689A (en) | 1,2,4-triazole derivatives as histamine h.sub.2- antagonists | |
| EP0071434A2 (en) | Heterocyclic derivatives | |
| JP4177841B2 (ja) | Ｎ−置換−ｎ’−置換−ウレア誘導体及び該誘導体を含有する医薬組成物 | |
| FR2659080A1 (fr) | Nouveaux derives de la pyridylsulfonyluree et de la pyridylsulfonylthiouree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
| JPH05163229A (ja) | 新規なシクロプロピル誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |